We develop and commercialize technologies for site-specific drug delivery to the Central Nervous System, in particular the brain, exploiting tailored drug delivery system.

Our Vision

We overcome barriers by delivering therapies directly to the brain.

Brain Implant Therapeutics (BIT) Pharma was founded in November 2015 by leaders from academia and industry and is based in Graz, Austria.

Technology Innovation

BIT Pharma technology is based on proprietary manufacturing process for tailored drug release at the site of action within the central nervous system (mainly the brain).

cGMP-compliant process

Development based on completely synthetic (no animal source), biodegradable, polymer system and hot melt extrusion process.

Intellectual Property

Preparations underway to broaden Intellectual Property base for additional applications.

Exclusive Manufacture

Possibility to secure exclusive manufacture of API and excipients for NicaPlant®.

Years of experience

The BIT Pharma Management Team embraces industry leading experience in preclinical and clinical development, drug delivery technologies, as well as successful experience in general management.

Contact Us

Send us an email for further inquiry.

Not readable? Change text.